# GutCRINE

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gutcrine-aps

- Industry: Biotechnology
- Headquarters: Denmark
- Total disclosed funding: $0.6M
- Latest round: Seed (Apr 11, 2023)
- Investors on record: 2

## About

Founded in 2023 and based in Denmark, Gutcrine ApS is a spinout company from the University of Copenhagen that develops drugs to treat neurological and metabolic conditions. Oluf Borbye Pedersen is the founder of the company. In April 2023, GutCRINE ApS raised DKK 4 million in seed funding from Eir Ventures and UCPH Ventures.

The company is developing a therapy targeting metabolic and age-related diseases like obesity, type 2 diabetes, osteoporosis, and Parkinson’s disease.

The organization plans to use the April 2023 funding to begin the development of biological medicines, known as pharmabiotics.

## Funding rounds

- Seed, Apr 11, 2023, $0.6M — Eir Ventures, UCPH Ventures

## Investors

- Eir Ventures (https://capitalatlas.ai/funds/eir-ventures) — Seed
- UCPH Ventures — Seed